Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The enhanced contractility of the phospholamban-deficient mouse heart persists with aging.

Journal of molecular and cellular cardiology - 1 May 2001

Slack J P, Grupp I L, Dash R, Holder D, Schmidt A, Gerst M J, Tamura T, Tilgmann C, James P F, Johnson R, Gerdes A M, Kranias E G

Abstract excerpt

J. P. Slack, I. L. Grupp, R. Dash, D. Holder, A. Schmidt, M. J. Gerst, T. Tamura, C. Tilgmann, P. F. James, R. Johnson, A. M. Gerdes and E. G. Kranias. The Enhanced Contractility of the Phospholamban-deficient Mouse Heart Persists with Aging. Journal of Molecular and Cellular Cardiology (2001) 33, 1031-1040. Phospholamban ablation in the mouse is associated with significant increases in cardiac contractility. To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aging

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Calcium-Binding Proteins

Share to Echocardiography

Share to Immunoblotting

Share to Myocardial Contraction

Share to Myocardium

Source

Identifiers

PMID: 11343424
DOI: 10.1006/jmcc.2001.1370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The enhanced contractility of the phospholamban-deficient mouse heart persists with aging.PMID 11343424Read ↗

Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics.Semantic proximity Read ↗

Phospholamban Cardiomyopathy: Unveiling a Distinct Phenotype Through Heart Failure Stages Progression.Semantic proximity Read ↗

Monomeric phospholamban overexpression in transgenic mouse hearts.Semantic proximity Read ↗

Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.Semantic proximity Read ↗

Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.Semantic proximity Read ↗

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.Semantic proximity Read ↗

Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity.Semantic proximity Read ↗

p38β/MAPK11 Deficiency Exacerbates Cardiac Structural and Electrophysiological Remodeling and Contributes to Immune Dysregulation in the Aging HeartSemantic proximity Read ↗

Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathySemantic proximity Read ↗

Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice.Semantic proximity Read ↗

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.Semantic proximity Read ↗

Phosphorylation of cardiac sodium channel at Ser571 anticipates manifestations of the aging myopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.